Search research articles
Contact Us
Filters
Showing results (731-740 of 754) with videos related to
Page
of 76
Sort By:
Journal of Medicinal Chemistry
|
January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)
Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
The Journal of Biological Chemistry
|
December 24, 2002
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
Celia P Briscoe, Mohammad Tadayyon, John L Andrews, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors
Ryan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2014
Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility
Robert M Rzasa, Michael J Frohn, Kristin L Andrews, et al.
Journal of the American College of Cardiology
|
December 28, 2010
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals
Ilan Goldenberg, Samuel Horr, Arthur J Moss, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors
Ryan P Wurz, Liping H Pettus, Claire Jackson, et al.
Circulation
|
August 28, 2016
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study
Arthur A M Wilde, Arthur J Moss, Elizabeth S Kaufman, et al.
Molecular Cancer Therapeutics
|
April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab
Beth Hutchins, Gary C Starling, Mark A McCoy, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept
Kate S Ashton, Kristin L Andrews, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
Victor J Cee, Frank Chavez, Bradley Herberich, et al.
Page
of 76
Search research articles
Search
Showing results (731-740 of 754) with videos related to
Sort By:
Page
of 76
Journal of Medicinal Chemistry
|
January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)
Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
The Journal of Biological Chemistry
|
December 24, 2002
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
Celia P Briscoe, Mohammad Tadayyon, John L Andrews, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors
Ryan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2014
Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility
Robert M Rzasa, Michael J Frohn, Kristin L Andrews, et al.
Journal of the American College of Cardiology
|
December 28, 2010
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals
Ilan Goldenberg, Samuel Horr, Arthur J Moss, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors
Ryan P Wurz, Liping H Pettus, Claire Jackson, et al.
Circulation
|
August 28, 2016
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study
Arthur A M Wilde, Arthur J Moss, Elizabeth S Kaufman, et al.
Molecular Cancer Therapeutics
|
April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab
Beth Hutchins, Gary C Starling, Mark A McCoy, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept
Kate S Ashton, Kristin L Andrews, Marian C Bryan, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
Victor J Cee, Frank Chavez, Bradley Herberich, et al.
Page
of 76